313 related articles for article (PubMed ID: 19618185)
21. Fast dendritic cells stimulated with alternative maturation mixtures induce polyfunctional and long-lasting activation of innate and adaptive effector cells with tumor-killing capabilities.
Massa C; Seliger B
J Immunol; 2013 Apr; 190(7):3328-37. PubMed ID: 23447683
[TBL] [Abstract][Full Text] [Related]
22. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
23. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
[TBL] [Abstract][Full Text] [Related]
24. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.
van Beek JJ; Wimmers F; Hato SV; de Vries IJ; Sköld AE
Crit Rev Immunol; 2014; 34(6):517-36. PubMed ID: 25597314
[TBL] [Abstract][Full Text] [Related]
26. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.
Srivastava RM; Lee SC; Andrade Filho PA; Lord CA; Jie HB; Davidson HC; López-Albaitero A; Gibson SP; Gooding WE; Ferrone S; Ferris RL
Clin Cancer Res; 2013 Apr; 19(7):1858-72. PubMed ID: 23444227
[TBL] [Abstract][Full Text] [Related]
27. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
Fujii S; Shimizu K; Smith C; Bonifaz L; Steinman RM
J Exp Med; 2003 Jul; 198(2):267-79. PubMed ID: 12874260
[TBL] [Abstract][Full Text] [Related]
28. Cellular cytotoxicity is a form of immunogenic cell death.
Minute L; Teijeira A; Sanchez-Paulete AR; Ochoa MC; Alvarez M; Otano I; Etxeberrria I; Bolaños E; Azpilikueta A; Garasa S; Casares N; Perez Gracia JL; Rodriguez-Ruiz ME; Berraondo P; Melero I
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217765
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic dendritic cells generated from cancer patients.
Lakomy D; Janikashvili N; Fraszczak J; Trad M; Audia S; Samson M; Ciudad M; Vinit J; Vergely C; Caillot D; Foucher P; Lagrost L; Chouaib S; Katsanis E; Larmonier N; Bonnotte B
J Immunol; 2011 Sep; 187(5):2775-82. PubMed ID: 21804019
[TBL] [Abstract][Full Text] [Related]
30. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.
Tel J; Schreibelt G; Sittig SP; Mathan TS; Buschow SI; Cruz LJ; Lambeck AJ; Figdor CG; de Vries IJ
Blood; 2013 Jan; 121(3):459-67. PubMed ID: 23212525
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cell biology and its role in tumor immunotherapy.
Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
[TBL] [Abstract][Full Text] [Related]
32. Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells.
Parajuli P; Mathupala S; Sloan AE
Neurosurgery; 2004 Nov; 55(5):1194-204. PubMed ID: 15509326
[TBL] [Abstract][Full Text] [Related]
33. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
34. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Cancel JC; Crozat K; Dalod M; Mattiuz R
Front Immunol; 2019; 10():9. PubMed ID: 30809220
[TBL] [Abstract][Full Text] [Related]
35. Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.
Hennies CM; Reboulet RA; Garcia Z; Nierkens S; Wolkers MC; Janssen EM
Clin Exp Immunol; 2011 Mar; 163(3):381-91. PubMed ID: 21235535
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
Anguille S; Lion E; Tel J; de Vries IJ; Couderé K; Fromm PD; Van Tendeloo VF; Smits EL; Berneman ZN
PLoS One; 2012; 7(12):e51851. PubMed ID: 23284789
[TBL] [Abstract][Full Text] [Related]
37. Licensing of killer dendritic cells in mouse and humans: functional similarities between IKDC and human blood γδ T-lymphocytes.
Anderson J; Gustafsson K; Himoudi N
J Immunotoxicol; 2012; 9(3):259-66. PubMed ID: 22632132
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells as killers: mechanistic aspects and potential roles.
Chauvin C; Josien R
J Immunol; 2008 Jul; 181(1):11-6. PubMed ID: 18566364
[TBL] [Abstract][Full Text] [Related]
39. Human anti-pig NK cell and CD8
Madelon N; Puga Yung GL; Seebach JD
Xenotransplantation; 2016 Nov; 23(6):479-489. PubMed ID: 27862343
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses.
Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA
J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]